Interim results of a multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC).

被引：3
|
作者：
Lacy, Jill
Portales, Fabienne
Hammel, Pascal
Cid, Roberto A. Pazo
Mozo, Jose Luis Manzano
Kim, Edward Jae-hoon
Dowden, Scot D.
Borg, Christophe
Sastre, Javier
Bathini, Venu Gopal
Terrebonne, Eric
Lopez-Trabada, Daniel
Rivera, Fernando
Asselah, Jamil
Damiani, Azzurra
Hwang, Jimmy J.
Ong, Teng Jin
Nydam, Thom
Li, Jack Shiansong
Philip, Philip Agop
机构：
[1] Yale Canc Ctr, New Haven, CT USA
[2] Inst Reg Canc Montpellier ICM, Montpellier, France
[3] Hop Beaujon, Clichy, France
[4] Hosp Miguel Servet, Zaragoza, Spain
[5] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[6] UC Davis Comprehens Canc Ctr, Sacramento, CA USA
[7] Tom Baker Canc Clin, Calgary, AB, Canada
[8] Ctr Hosp Belfort Montbeliard, Montbeliard, France
[9] Hosp Clin San Carlos, Madrid, Spain
[10] Univ Massachusetts, Sch Med, Canc Ctr Excellence, Worcester, MA USA
[11] Hop Haut Leveque, Giround, France
[12] Hop St Antoine, Paris, France
[13] Hosp Univ Marques de Valdecilla, Santander, Spain
[14] McGill Univ, Royal Inst, Montreal, PQ, Canada
[15] Azienda Osped Univ San Martino, Genoa, Italy
[16] Georgetown Univ, Dept Med & Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA
[17] Georgetown Univ, Innovat Ctr Biomed Informat, Lombardi Comprehens Canc Ctr, Washington, DC USA
[18] Celgene Corp, Summit, NJ USA
[19] Karmanos Canc Ctr, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
358
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC).
    Hammel, Pascal
    Lacy, Jill
    Portales, Fabienne
    Sobrero, Alberto F.
    Cid, Roberto A. Pazo
    Mozo, Jose Luis Manzano
    Mozo, Manzano
    Terrebonne, Eric
    Dowden, Scot D.
    Li, Jack Shiansong
    Ong, Teng Jin
    Nydam, Thom
    Philip, Philip Agop
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT Trial
    Philip, P. A.
    Lacy, J.
    Portales, F.
    Sobrero, A.
    Pazo-Cid, R.
    Manzano Mozo, J. L.
    Kim, E. S.
    Dowden, S.
    Zakari, A.
    Borg, C.
    Terrebonne, E.
    Rivera Herrero, F.
    Shiansong Li, J.
    Ong, T. J.
    Nydam, T.
    Hammel, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] LAPACT: An open-label, multicenter phase II trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC).
    Philip, Philip Agop
    Lacy, Jill
    Dowden, Scot D.
    Sastre, Javier
    Bathini, Venu Gopal
    Cardin, Dana Backlund
    Ma, Wen Wee
    Sobrero, Alberto F.
    Koski, Sheryl L.
    Borg, Christophe
    Tonini, Giuseppe
    Rivera, Fernando
    Hwang, Jimmy J.
    Knoble, Jeanna L.
    Al Baghdadi, Tareq
    Saif, Wasif M.
    Meiri, Eyal
    Kayitalire, Louis
    Li, Jack
    Hammel, Pascal
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [4] Gemcitabine (G) plus nab-paclitaxel (nab-P) plus chemoradiation (CRT) in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga Olanrele
    Bedoya, Ivan Dario
    Mierzwa, Michelle Lynn
    Torregroza, Maria Patricia
    Dwivedi, Alok Kumar
    Wang, Jiang
    Smith, Milton T.
    Schmulewitz, Nathan
    Kucera, Stephen
    Choe, Kyuran Ann
    Ristagno, Ross
    Rudich, Steven
    Sussman, Jeffrey J.
    Ahmad, Syed A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] International phase II trial of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients with locally advanced pancreatic cancer (LAPC): LAPACT
    Philip, P.
    Kayitalire, L.
    Nydam, T.
    Penenberg, D.
    Hammel, P.
    ANNALS OF ONCOLOGY, 2015, 26
  • [6] Interim health related quality of life (QoL) from LAPACT, a Phase 2 trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC)
    Portales, F.
    Philip, P. A.
    Hammel, P.
    Buscaglia, M.
    Pazo-Cid, R.
    Manzano Mozo, J. L.
    Kim, E. S.
    Dowden, S.
    Zakari, A.
    Borg, C.
    Terrebonne, E.
    Rivera Herrero, F.
    Li, J. Shiansong
    Ong, T. J.
    Nydam, T.
    Lacy, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] The international, open-label, multicenter phase 2 LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) for patients with locally advanced pancreatic cancer (LAPC)
    Pascal, Hammel
    Jill, Lacy
    Fabienne, Portales
    Alberto, Sobrero
    Beatriz, Garca-Paredes
    Edward, Kim
    Fernando, Rivera
    Jose Luis, Manzano
    Eric, Terrebonne
    Venu, Bathini
    Scot, Dowden
    Jamil, Asselah
    Jack, Shiansong Li
    Thomas, Nydam
    Louis, Kayitalire
    Philip, Philip
    ANNALS OF ONCOLOGY, 2016, 27 : 78 - 79
  • [8] Gemcitabine (Gem) and nab-paclitaxel (nab-P) in patients (pts) with refractory advanced pancreatic cancer
    Palacio, Sofia
    Akunyili, Ikechukwu Immanuel
    Ernani, Vinicius
    Macintyre, Jessica
    Merchan, Jaime R.
    Pollack, Terri
    Reis, Isildinha
    Restrepo, Maria H.
    Lima, Caio Max S. Rocha
    Hosein, Peter Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [9] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [10] nab-paclitaxel (nab-P) plus nivolumab (Nivo) ± gemcitabine (Gem) in patients (pts) with advanced pancreatic cancer (PC).
    Firdaus, Irfan
    Waterhouse, David Michael
    Gutierrez, Martin
    Wainberg, Zev A.
    George, Ben
    Kelly, Karen
    Bekaii-Saab, Tanios S.
    Carrizosa, Daniel R.
    Soliman, Hatem Hussein
    Fraser, Cindy Duval
    Ko, Amy
    Pierce, Daniel W.
    Manax, Victoria G.
    Stergiopoulos, Sotirios G.
    Hochster, Howard S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345